The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research permits BLB to provide key strategic consultancy to our partners
We aim at accelerating the development of new biopharmaceutical compounds, being helpful at any stage of their development: from the very beginning of your pipeline to the design and execution of phase 3 trials.
The complete pre-clinical Solution
EXOLIVER®
BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers